MILAN — Combining polatuzumab vedotin (Pola) with rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improves survival outcomes in patients with transplant-ineligible, relapsed ...

A federal judge has signed off on arguably the biggest change in the history of college sports, clearing the way for schools to begin paying their athletes millions of dollars as soon as next month.